SS Innovations International (SSII) Enterprise Value Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.51% |
| Dec 31, 2025 | -45.03% |
| Sep 30, 2025 | -102.50% |
| Jun 30, 2025 | -2,021.79% |
| Mar 31, 2025 | -231.27% |
| Dec 31, 2024 | 10.59% |
| Sep 30, 2024 | 50.20% |
| Jun 30, 2024 | -74.43% |
| Mar 31, 2024 | -1,364.41% |
| Dec 31, 2023 | -2,467.84% |
| Sep 30, 2023 | -2,157.51% |
| Jun 30, 2023 | -78.62% |
| Mar 31, 2023 | -29.31% |
| Dec 31, 2022 | 32.32% |
| Sep 30, 2022 | -150.56% |
| Jun 30, 2022 | 15.11% |
| Mar 31, 2022 | -9.49% |
| Dec 31, 2021 | -152.49% |
| Sep 30, 2021 | -29,855.47% |
| Jun 30, 2021 | -5,578.82% |
| Mar 31, 2021 | -3,030.56% |
| Dec 31, 2020 | -464.41% |
| Sep 30, 2020 | 97.71% |
| Jun 30, 2020 | 86.15% |
| Mar 31, 2020 | 83.55% |
| Dec 31, 2019 | 20.28% |
| Sep 30, 2019 | 70.09% |
| Jun 30, 2019 | 79.61% |
| Mar 31, 2019 | 80.45% |
| Dec 31, 2018 | 92.11% |
| Sep 30, 2018 | 80.77% |
| Jun 30, 2018 | -47.96% |
| Mar 31, 2018 | -23.17% |
| Dec 31, 2017 | -82.33% |
| Sep 30, 2017 | -80.40% |
| Jun 30, 2017 | 65.00% |